BRIC Healthcare Reforms Create Opportunities - EurasiaBio
This article was originally published in PharmAsia News
Executive Summary
MOSCOW - The U.S. is not alone in reforming its national healthcare system. The world's emerging markets such as China, India, Brazil and Russia face similar problems, and biotech companies that adapt to the changing landscape will win big in a consumer-driven healthcare system, according to Steven Burrill, president of private equity firm Burrill & Company
You may also be interested in...
Leaders In Russia, India, China Mark Bio-clusters As Key To Fostering Local Innovation
Government leaders across India, Russia and China are increasing support for the creation of bio-clusters to accelerate biopharmaceutical research and development
Leaders In Russia, India, China Mark Bio-clusters As Key To Fostering Local Innovation
Government leaders across India, Russia and China are increasing support for the creation of bio-clusters to accelerate biopharmaceutical research and development
Chinese API Manufacturer Expands International Presence, Provides Funding For U.S. Startup
Venture funds are expanding throughout Asia, and government groups are establishing funds to draw business, but there are also signs that Asian pharmaceutical firms are looking to invest in Western startups and are turning their gaze beyond their own borders